Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NovaBay Pharmaceuticals Inc (NYSE American:NBY)

4.30
Delayed Data
As of Oct 20
 -0.15 / -3.37%
Today’s Change
2.25
Today|||52-Week Range
5.09
+30.30%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash10.5M5.4M2.4M9.5M
 
 
 
 
 
Short Term Investment Cash-2.2M-5.1M-3.0M7.1M
 
 
 
 
 
Cash & Short Term Investments13.1M5.4M2.4M9.5M
 
 
 
 
 
 
ReceivablesReceivables784.0K273.0K536.0K2.1M
 
 
 
 
 
 
InventoriesInventories231.0K521.0K1.3M873.0K
 
 
 
 
 
 
Current AssetsOther Current Assets723.0K729.0K261.0K2.0M
 
 
 
 
 
Current Assets14.8M7.0M4.5M14.5M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross2.4M2.0M2.1M520.0K
 
 
 
 
 
Depreciation-1.6M-1.5M-1.7M-149.0K
 
 
 
 
 
Other Assets141.0K149.0K155.0K539.0K
 
 
 
 
 
Total Assets15.7M7.5M5.1M15.4M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.7M1.9M2.5M455.0K
 
 
 
 
 
Accrued Expenses767.0K388.0K776.0K1.8M
 
 
 
 
 
Other Current Liabilities1.1M813.0K946.0K3.9M
 
 
 
 
 
Other Liabilities3.6M3.3M4.6M4.3M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.000.001.7M0.00
 
 
Other Liabilities1.8M173.0K1.6M2.0M
 
 
 
 
 
Total Liabilities7.1M5.7M10.2M8.3M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity8.5M1.8M-5.1M7.1M
 
 
 
 
 
Total Shareholder Equity8.5M1.8M-5.1M7.1M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding1.8M2.1M3.5M15.3M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.